Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Functional Foods
  4. Fast Track Articles
  5. Fast Track Article
image of A Review on Functional Foods and Nutraceuticals in the Management of Epilepsy

Abstract

Epilepsy is a persistent neurological disorder distinguished by repetitive episodes of seizures that presents notable complexities for patients and healthcare providers. While pharmacotherapy remains fundamental in its management, the emergence of functional foods and nutraceuticals has garnered attention as adjunctive therapeutic options. This review examines the role of functional foods and nutraceuticals in epilepsy management, examining their mechanisms of action, evidence-based efficacy, and safety profiles. The review delineates various functional foods and nutraceuticals exhibiting promise in epilepsy management, encompassing omega-3 fatty acids, the ketogenic diet, flavonoids, vitamins, and minerals. Mechanically, these substances modulate neuronal excitability, neurotransmitter release, and neuroinflammation, thus exerting anticonvulsant effects. Furthermore, they may augment the efficacy of conventional antiepileptic drugs while mitigating their adverse effects. Clinical investigations assessing the efficacy of functional foods and nutraceuticals in epilepsy management have yielded encouraging findings, albeit necessitating further inquiry to ascertain optimal dosing protocols and long-term safety considerations. Additionally, challenges such as bioavailability, formulation standardization, and patient adherence warrant attention to optimize therapeutic outcomes.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cff/10.2174/0126668629329853241028081157
2024-12-03
2025-04-06

  • From This Site

    /content/journals/cff/10.2174/0126668629329853241028081157
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. WHO, Epilepsy. 2024 Available from:https://www.who.int/news-room/fact-sheets/detail/epilepsy#:~:text=Rates%20of%20disease,Epilepsy%20accounts%20for%20a%20significant%20proportion%20of%20the%20world's%20disease,and%2010%20per%201000%20people(accessed on 8-10-2024)
  2. Zack M. Kobau R. Letter re: Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology 2017 89 6 641 641 10.1212/WNL.0000000000004205 28784638
    [Google Scholar]
  3. Ogunniyi A. Global evidence generation. Oxford Textbook of Neurologic and Neuropsychiatric Epidemiology Oxford Academic 2020
    [Google Scholar]
  4. Feigin V.L. Vos T. Alahdab F. Amit A.M.L. Bärnighausen T.W. Beghi E. Beheshti M. Chavan P.P. Criqui M.H. Desai R. Dhamminda Dharmaratne S. Dorsey E.R. Wilder Eagan A. Elgendy I.Y. Filip I. Giampaoli S. Giussani G. Hafezi-Nejad N. Hole M.K. Ikeda T. Owens Johnson C. Kalani R. Khatab K. Khubchandani J. Kim D. Koroshetz W.J. Krishnamoorthy V. Krishnamurthi R.V. Liu X. Lo W.D. Logroscino G. Mensah G.A. Miller T.R. Mohammed S. Mokdad A.H. Moradi-Lakeh M. Morrison S.D. Shivamurthy V.K.N. Naghavi M. Nichols E. Norrving B. Odell C.M. Pupillo E. Radfar A. Roth G.A. Shafieesabet A. Sheikh A. Sheikhbahaei S. Shin J.I. Singh J.A. Steiner T.J. Stovner L.J. Wallin M.T. Weiss J. Wu C. Zunt J.R. Adelson J.D. Murray C.J.L. Burden of neurological disorders across the US from 1990-2017: a global burden of disease study. JAMA Neurol. 2021 78 2 165 176 10.1001/jamaneurol.2020.4152 33136137
    [Google Scholar]
  5. Chernov D. Sornette D. Chernov D. Sornette D. Specific features of risk management in the industrial and agricultural sectors. Critical Risks of Different Economic Sectors: Based on the Analysis of More Than 500 Incidents, Accidents and Disasters Springer 2020 10.1007/978‑3‑030‑25034‑8_2
    [Google Scholar]
  6. Ali Arazeem A. Tahirah Adedolapo I. Joseph Alabi O. Shame, stigma, and social exclusion: The lived experiences of epileptic patients in a health facility in Ilorin, Nigeria. Glob. Public Health 2022 17 12 3839 3852 10.1080/17441692.2022.2092174 35748774
    [Google Scholar]
  7. Ogunsuyi O.B. Aro P.O. Umar H.I. Oboh G. Administration of Curcumin plus Treadmill Exercise Modulate Some Neuronal Enzyme Activities, Redox Markers and BDNF mRNA Expression in Pilocarpine-Induced Epileptic Seizure in Rats. Neurochem. J. 2023 17 3 467 476 10.1134/S1819712423030145
    [Google Scholar]
  8. St Louis E.K. Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care. Curr. Neuropharmacol. 2009 7 2 106 114 10.2174/157015909788848857 19949568
    [Google Scholar]
  9. Ogunsuyi O.B. Adeoyo O. Oboh G. Food-Drug Interaction: New Paradigm in Therapeutic Potentials of Functional Foods. Functional Foods: Unlocking the medicine in foods Graceland Prints 2017
    [Google Scholar]
  10. Oboh G. Ademosun A.O. Ogunsuyi O.B. Quercetin and its role in chronic diseases. Adv. Exp. Med. Biol. 2016 929 377 387 10.1007/978‑3‑319‑41342‑6_17 27771934
    [Google Scholar]
  11. Kim J.H. Kim D.H. Jo S. Cho M.J. Cho Y.R. Lee Y.J. Byun S. Immunomodulatory functional foods and their molecular mechanisms. Exp. Mol. Med. 2022 54 1 1 11 10.1038/s12276‑022‑00724‑0 35079119
    [Google Scholar]
  12. Venkatakrishnan K. Chiu H.F. Wang C.K. Impact of functional foods and nutraceuticals on high blood pressure with a special focus on meta-analysis: review from a public health perspective. Food Funct. 2020 11 4 2792 2804 10.1039/D0FO00357C 32248209
    [Google Scholar]
  13. Ajeeshkumar K.K. Aneesh P.A. Raju N. Suseela M. Ravishankar C.N. Benjakul S. Advancements in liposome technology: Preparation techniques and applications in food, functional foods, and bioactive delivery: A review. Compr. Rev. Food Sci. Food Saf. 2021 20 2 1280 1306 10.1111/1541‑4337.12725 33665991
    [Google Scholar]
  14. Nataraj B.H. Ali S.A. Behare P.V. Yadav H. Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods. Microb. Cell Fact. 2020 19 1 168 10.1186/s12934‑020‑01426‑w 32819443
    [Google Scholar]
  15. Granato D. Barba F.J. Bursać Kovačević D. Lorenzo J.M. Cruz A.G. Putnik P. Functional Foods: Product Development, Technological Trends, Efficacy Testing, and Safety. Annu. Rev. Food Sci. Technol. 2020 a 11 1 93 118 10.1146/annurev‑food‑032519‑051708 31905019
    [Google Scholar]
  16. Sarmast S.T. Abdullahi A.M. Jahan N. Current Classification of Seizures and Epilepsies: Scope, Limitations and Recommendations for Future Action. Cureus 2020 12 9 e10549 10.7759/cureus.10549 33101797
    [Google Scholar]
  17. De Oliveira Costa L.L. Brandão E.C. Segundo L.M.D.B.M. Update on epilepsy: literature review. Rev. Med. (São Paulo) 2020 99 2 170 181
    [Google Scholar]
  18. Riney K. Bogacz A. Somerville E. Hirsch E. Nabbout R. Scheffer I.E. ILAE Classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions. Currently in Review by the ILAE. 2021 Available from:https://www. ilae. org/guidelines/definition-and-classification/proposed-classificationand-definition-of-epilepsy-syndromes/proposed-classification-syndromeswith-onset-at-variable-ages(accessed on 8-10-2024)
  19. Nascimento F.A. Friedman D. Peters J.M. Bensalem-Owen M.K. Cendes F. Rampp S. Wirrell E. Blümcke I. Tatum W. Beniczky S. Focal epilepsies: Update on diagnosis and classification. Epileptic Disord. 2023 25 1 1 17 10.1002/epd2.20045 36938903
    [Google Scholar]
  20. Chowdhury F.A. Silva R. Whatley B. Walker M.C. Localisation in focal epilepsy: a practical guide. Pract. Neurol. 2021 21 6 481 491 10.1136/practneurol‑2019‑002341 34404748
    [Google Scholar]
  21. Kang J.Q. Epileptic mechanisms shared by Alzheimer’s disease: Viewed via the unique lens of genetic epilepsy. Int. J. Mol. Sci. 2021 22 13 7133 10.3390/ijms22137133 34281185
    [Google Scholar]
  22. Sumadewi K.T. Harkitasari S. Tjandra D.C. Biomolecular mechanisms of epileptic seizures and epilepsy: a review. Acta Epileptol. 2023 5 1 28 10.1186/s42494‑023‑00137‑0
    [Google Scholar]
  23. Fisher R.S. Acharya J.N. Baumer F.M. French J.A. Parisi P. Solodar J.H. Szaflarski J.P. Thio L.L. Tolchin B. Wilkins A.J. Kasteleijn-Nolst Trenité D. Visually sensitive seizures: An updated review by the Epilepsy Foundation. Epilepsia 2022 63 4 739 768 10.1111/epi.17175 35132632
    [Google Scholar]
  24. Patel P. Moshé S.L. The evolution of the concepts of seizures and epilepsy: What’s in a name? Epilepsia Open 2020 5 1 22 35 10.1002/epi4.12375 32140641
    [Google Scholar]
  25. Bartolomei F.A. Blumenfeld H. Epilepsy and consciousness. Neurobiology of the Epilepsies: From Epilepsy: A Comprehensive Textbook Lippincott Williams & Wilkins 2022
    [Google Scholar]
  26. Mohammed Mohammed Ashry A.A. Farwiz H.M. Abdelrasoul R.B. Semiology of epileptic seizures: Assiut University Hospital-based study. Journal of Current Medical Research and Practice 2021 6 2 128 133 10.4103/JCMRP.JCMRP_71_19
    [Google Scholar]
  27. Mantoan Ritter L. Nilsson C. Seizures and epilepsy in dementia: Diagnosis and management. Management of patients with dementia: The role of the physician Springer Nature 2021 10.1007/978‑3‑030‑77904‑7_12
    [Google Scholar]
  28. Aung T. Tenney J.R. Bagić A.I. Contributions of magnetoencephalography to Understanding mechanisms of generalized epilepsies: Blurring the boundary between focal and generalized epilepsies? Front. Neurol. 2022 13 831546 10.3389/fneur.2022.831546 35572923
    [Google Scholar]
  29. San-Juan D. Rodríguez-Méndez D.A. Epilepsy as a disease affecting neural networks: a neurophysiological perspective. Neurología (Engl. Ed.) 2023 38 2 114 123 10.1016/j.nrleng.2020.06.016 36396092
    [Google Scholar]
  30. Carboni M. De Stefano P. Vorderwülbecke B.J. Tourbier S. Mullier E. Rubega M. Momjian S. Schaller K. Hagmann P. Seeck M. Michel C.M. van Mierlo P. Vulliemoz S. Abnormal directed connectivity of resting state networks in focal epilepsy. Neuroimage Clin. 2020 27 102336 10.1016/j.nicl.2020.102336 32679553
    [Google Scholar]
  31. Sarlo G.L. Holton K.F. Brain concentrations of glutamate and GABA in human epilepsy: A review. Seizure 2021 91 213 227 10.1016/j.seizure.2021.06.028 34233236
    [Google Scholar]
  32. Cherubini E. Di Cristo G. Avoli M. Dysregulation of GABAergic signaling in neurodevelomental disorders: targeting cation-chloride co-transporters to re-establish a proper E/I balance. Front. Cell. Neurosci. 2022 15 813441 10.3389/fncel.2021.813441 35069119
    [Google Scholar]
  33. Hallett M. DelRosso L.M. Elble R. Ferri R. Horak F.B. Lehericy S. Mancini M. Matsuhashi M. Matsumoto R. Muthuraman M. Raethjen J. Shibasaki H. Evaluation of movement and brain activity. Clin. Neurophysiol. 2021 132 10 2608 2638 10.1016/j.clinph.2021.04.023 34488012
    [Google Scholar]
  34. Frey K. Zöllner J.P. Knake S. Oganian Y. Kay L. Mahr K. Keil F. Willems L.M. Menzler K. Bauer S. Schubert-Bast S. Rosenow F. Strzelczyk A. Risk incidence of fractures and injuries: a multicenter video-EEG study of 626 generalized convulsive seizures. J. Neurol. 2020 267 12 3632 3642 10.1007/s00415‑020‑10065‑5 32651672
    [Google Scholar]
  35. Kaul S. Babu P. S. Epileptic Seizures. MIMICS of Epileptic Seizures Jaypee Brothers Medical Publishers 2020
    [Google Scholar]
  36. Ramesh V. Managing Epilepsy in Low Resource Settings. Child Refugee and Migrant Health: A Manual for Health Professionals. Cham Springer International Publishing 2021 425 440 10.1007/978‑3‑030‑74906‑4_30
    [Google Scholar]
  37. van der Veen S. Caviness J.N. Dreissen Y.E.M. Ganos C. Ibrahim A. Koelman J.H.T.M. Stefani A. Tijssen M.A.J. Myoclonus and other jerky movement disorders. Clin. Neurophysiol. Pract. 2022 7 285 316 10.1016/j.cnp.2022.09.003 36324989
    [Google Scholar]
  38. Samia P. Wilmshurst J. M. Common childhood epilepsy mimics. Clinical Child Neurology Springer 2020 10.1007/978‑3‑319‑43153‑6_23
    [Google Scholar]
  39. Anwar H. Khan Q.U. Nadeem N. Pervaiz I. Ali M. Cheema F.F. Epileptic seizures. Discoveries (Craiova) 2020 8 2 e110 10.15190/d.2020.7 32577498
    [Google Scholar]
  40. Crunelli V. Lőrincz M.L. McCafferty C. Lambert R.C. Leresche N. Di Giovanni G. David F. Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures. Brain 2020 143 8 2341 2368 10.1093/brain/awaa072 32437558
    [Google Scholar]
  41. Rinaldi V.E. Di Cara G. Mencaroni E. Verrotti A. Therapeutic options for childhood absence epilepsy. Pediatr. Rep. 2021 13 4 658 667 10.3390/pediatric13040078 34941639
    [Google Scholar]
  42. Manole A. Sirbu C. Mititelu M. Vasiliu O. Lorusso L. Sirbu O. Ionita Radu F. State of the art and challenges in epilepsy—a narrative review. J. Pers. Med. 2023 13 4 623 10.3390/jpm13040623 37109008
    [Google Scholar]
  43. Barone V. van Putten M.J.A.M. Visser G.H. Absence epilepsy: Characteristics, pathophysiology, attention impairments, and the related risk of accidents. A narrative review. Epilepsy Behav. 2020 112 107342 10.1016/j.yebeh.2020.107342 32861896
    [Google Scholar]
  44. Howard R. Kullmann D. Paget A. Spillane J. Waraich M. Disorders of Consciousness and Intensive Care Neurology. Neurology: A Queen Square Textbook Wiley 2024 10.1002/9781119715672.ch28
    [Google Scholar]
  45. Zawar I. Toribio M.G.G. Xu X. Alnakhli R.S. Benech D. Valappil A.M.N. Wyllie E. Burgess R. Kotagal P. Lachhwani D. Gupta A. Knight E.P. Epilepsy with Eyelid myoclonias − A diagnosis concealed in other genetic generalized epilepsies with photoparoxysmal response. Epilepsy Res. 2022 181 106886 10.1016/j.eplepsyres.2022.106886 35180638
    [Google Scholar]
  46. Zhao L. Sun Z. Yang L. Cui R. Yang W. Li B. Neuropharmacological effects of aconiti lateralis radix praeparata. Clin. Exp. Pharmacol. Physiol. 2020 47 4 531 542 10.1111/1440‑1681.13228 31837236
    [Google Scholar]
  47. Hermann B.P. Struck A.F. Busch R.M. Reyes A. Kaestner E. McDonald C.R. Neurobehavioural comorbidities of epilepsy: towards a network-based precision taxonomy. Nat. Rev. Neurol. 2021 17 12 731 746 10.1038/s41582‑021‑00555‑z 34552218
    [Google Scholar]
  48. Shlobin N.A. Singh G. Newton C.R. Sander J.W. Classifying epilepsy pragmatically: Past, present, and future. J. Neurol. Sci. 2021 427 117515 10.1016/j.jns.2021.117515 34174531
    [Google Scholar]
  49. Wirrell E.C. Riney K. Specchio N. Zuberi S.M. How have the recent updated epilepsy classifications impacted on diagnosis and treatment? Expert Rev. Neurother. 2023 23 11 969 980 10.1080/14737175.2023.2254937 37676056
    [Google Scholar]
  50. Reis F.S. Martins A. Vasconcelos M.H. Morales P. Ferreira I.C.F.R. Functional foods based on extracts or compounds derived from mushrooms. Trends Food Sci. Technol. 2017 66 48 62 10.1016/j.tifs.2017.05.010
    [Google Scholar]
  51. Pisani F. Spagnoli C. What are the considerations when initiating treatment for epilepsy in children? Expert Rev. Neurother. 2023 23 12 1081 1096 10.1080/14737175.2023.2288107 38032395
    [Google Scholar]
  52. Falace A. Volpedo G. Scala M. Zara F. Striano P. Fassio A. V-ATPase Dysfunction in the Brain: Genetic Insights and Therapeutic Opportunities. Cells 2024 13 17 1441 10.3390/cells13171441 39273013
    [Google Scholar]
  53. Chandrasekara A. Josheph Kumar T. Roots and Tuber Crops as Functional Foods: A Review on Phytochemical Constituents and Their Potential Health Benefits. Int. J. Food Sci. 2016 2016 1 15 10.1155/2016/3631647 27127779
    [Google Scholar]
  54. Nilsson J. Sterner O. Modulation of GABA(A) receptors by natural products and the development of novel synthetic ligands for the benzodiazepine binding site. Curr. Drug Targets 2011 12 11 1674 1688 10.2174/138945011798109509 21561420
    [Google Scholar]
  55. Zhu H.L. Wan J.B. Wang Y.T. Li B.C. Xiang C. He J. Li P. Medicinal compounds with antiepileptic/anticonvulsant activities. Epilepsia 2014 55 1 3 16 10.1111/epi.12463 24299155
    [Google Scholar]
  56. Varzakas T. Zakynthinos G. Verpoort F. Plant Food Residues as a Source of Nutraceuticals and Functional Foods. Foods 2016 5 4 88 10.3390/foods5040088 28231183
    [Google Scholar]
  57. Ogunsuyi O.B. Ogunruku O.O. Umar H.I. Oboh G. Effect of curcumin–donepezil combination on spatial memory, astrocyte activation, and cholinesterase expressions in brain of scopolamine-treated rats. Mol. Biol. Rep. 2024 51 1 864 10.1007/s11033‑024‑09712‑1 39073463
    [Google Scholar]
  58. Buenafe O.E. Orellana-Paucar A. Maes J. Huang H. Ying X. De Borggraeve W. Crawford A.D. Luyten W. Esguerra C.V. de Witte P. Tanshinone IIA exhibits anticonvulsant activity in zebrafish and mouse seizure models. ACS Chem. Neurosci. 2013 4 11 1479 1487 10.1021/cn400140e 23937066
    [Google Scholar]
  59. Lin T.Y. Lu C.W. Huang S.K. Wang S.J. Tanshinone IIA, a constituent of Danshen, inhibits the release of glutamate in rat cerebrocortical nerve terminals. J. Ethnopharmacol. 2013 147 2 488 496 10.1016/j.jep.2013.03.045 23542145
    [Google Scholar]
  60. Tan X. Cheng X. Yang Y. Yan L. Gu J. Li H. Zeng X. Cao J. Tanshinone II-A sodium sulfonate (DS-201) enhances human BKCa channel activity by selectively targeting the pore-forming α subunit. Acta Pharmacol. Sin. 2014 35 11 1351 1363 10.1038/aps.2014.85 25345746
    [Google Scholar]
  61. He X.Q. Huang J.M. Liu G.J. Li J. Fu X.P. Effect of pueraria flavone on NF-kB mrna and il-10mrna expression in hippocampus of epileptic rats. Chin. Foreign Med. Res. 2019 17 13 15
    [Google Scholar]
  62. Sheng F. Chen M. Tan Y. Xiang C. Zhang M. Li B. Su H. He C. Wan J. Li P. Protective effects of otophylloside N on pentylenetetrazol-induced neuronal injury in vitro and in vivo. Front. Pharmacol. 2016 7 224 10.3389/fphar.2016.00224 27504096
    [Google Scholar]
  63. Tambe R. Patil A. Jain P. Sancheti J. Somani G. Sathaye S. Assessment of luteolin isolated from Eclipta alba leaves in animal models of epilepsy. Pharm. Biol. 2017 55 1 264 268 10.1080/13880209.2016.1260597 27927066
    [Google Scholar]
  64. Pan X. Li Z. Zhou Q. Shen H. Wu K. Huang X. Chen J. Zhang J. Zhu X. Lei J. Xiong W. Gong H. Xiao B. Yan N. Structure of the human voltage-gated sodium channel Na v 1.4 in complex with β1. Science 2018 362 6412 eaau2486 10.1126/science.aau2486 30190309
    [Google Scholar]
  65. Kim S.R. Control of granule cell dispersion by natural materials such as eugenol and naringin: a potential therapeutic strategy against temporal lobe epilepsy. J. Med. Food 2016 19 8 730 736 10.1089/jmf.2016.3712 27404051
    [Google Scholar]
  66. Shao H. Yang Y. Mi Z. Zhu G. Qi A. Ji W. Zhu Z. Anticonvulsant effect of Rhynchophylline involved in the inhibition of persistent sodium current and NMDA receptor current in the pilocarpine rat model of temporal lobe epilepsy. Neuroscience 2016 337 337 355 369 10.1016/j.neuroscience.2016.09.029 27670903
    [Google Scholar]
  67. Vanella R. 2015
  68. Xie W. Chen W.J. Meng C.X. Effect of Bupleuronin A on p-glycoprotein expression in multidrug resistant epileptic rats. Chin. J. E. Formulol. 2013 19 229 9903
    [Google Scholar]
  69. Lee J.M. Hong J. Moon G.J. Jung U.J. Won S.Y. Kim S.R. Morin prevents granule cell dispersion and neurotoxicity via suppression of mTORC1 in a kainic acid-induced seizure model. Exp. Neurobiol. 2018 27 3 226 237 10.5607/en.2018.27.3.226 30022874
    [Google Scholar]
  70. Yuan S.Y. Liu J.M. Advances in the pharmacology of α-asarum. J. Integrat. Chin. West. Med. Cardio Cerebrovascul. Dis. 2020 18 67 69
    [Google Scholar]
  71. Park G.Y. Kim Y.S. Kim Y.H. Shin S.W. Cho S.H. Eum K.S. Hong S-R. Yoon M-H. Omega-3 Oxidation State of Fish and Algae Oil Supplements in South Korea. Hangug. Sigpum Wisaeng Anjeonseong Haghoeji 2019 34 5 480 488 10.13103/JFHS.2019.34.5.480
    [Google Scholar]
  72. Schlanger S. Shinitzky M. Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 2002 43 1 103 104 10.1046/j.1528‑1157.2002.13601.x 11879394
    [Google Scholar]
  73. Yuen A.W.C. Flugel D. Poepel A. Bell G.S. Peacock J.L. Sander J.W. Non-randomized open trial of eicosapentaenoic acid (EPA), an omega-3 fatty acid, in ten people with chronic epilepsy. Epilepsy Behav. 2012 23 3 370 372 10.1016/j.yebeh.2011.11.030 22342198
    [Google Scholar]
  74. Dahlin M. Hjelte L. Nilsson S. Åmark P. Plasma phospholipid fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy. Epilepsy Res. 2007 73 2 199 207 10.1016/j.eplepsyres.2006.10.005 17150333
    [Google Scholar]
  75. Kim J.E. Cho K.O. Functional Nutrients for Epilepsy. Nutrients 2019 a 11 6 1309 10.3390/nu11061309 31185666
    [Google Scholar]
  76. Holló A. Clemens Z. Kamondi A. Lakatos P. Szűcs A. Correction of vitamin D deficiency improves seizure control in epilepsy: A pilot study. Epilepsy Behav. 2012 24 1 131 133 10.1016/j.yebeh.2012.03.011 22503468
    [Google Scholar]
  77. Zakharova I. Sokolova T. Vlasova Y. Bayunova L. Rychkova M. Avrova N. Alpha-tocopherol at nanomolar concentration protects cortical neurons against oxidative stress. Int. J. Mol. Sci. 2017 18 1 216 10.3390/ijms18010216 28117722
    [Google Scholar]
  78. Akomolafe S.F. Akinyemi A.J. Ogunsuyi O.B. Oyeleye S.I. Oboh G. Adeoyo O.O. Allismith Y.R. Effect of caffeine, caffeic acid and their various combinations on enzymes of cholinergic, monoaminergic and purinergic systems critical to neurodegeneration in rat brain—In vitro. Neurotoxicology 2017 62 6 13 10.1016/j.neuro.2017.04.008 28465162
    [Google Scholar]
  79. Akinyemi A.J. Oboh G. Oyeleye S.I. Ogunsuyi O. Anti-amnestic Effect of Curcumin in Combination with Donepezil, an Anticholinesterase Drug: Involvement of Cholinergic System. Neurotox. Res. 2017 31 4 560 569 10.1007/s12640‑017‑9701‑5 28102474
    [Google Scholar]
  80. Prakash C. Tyagi J. Rabidas S.S. Kumar V. Sharma D. Therapeutic Potential of Quercetin and its Derivatives in Epilepsy: Evidence from Preclinical Studies. Neuromolecular Med. 2023 25 2 163 178 10.1007/s12017‑022‑08724‑z 35951285
    [Google Scholar]
  81. Ogunsuyi O.B. Ademiluyi A.O. Oboh G. Oyeleye S.I. Dada A.F. Green leafy vegetables from two Solanum spp. ( Solanum nigrum L and Solanum macrocarpon L) ameliorate scopolamine‐induced cognitive and neurochemical impairments in rats. Food Sci. Nutr. 2018 6 4 860 870 10.1002/fsn3.628 29983948
    [Google Scholar]
  82. Rodriguez E.B. Flavier M.E. Rodriguez-Amaya D.B. Amaya-Farfán J. Phytochemicals and functional foods. Current situation and prospect for developing countries. Segur. Aliment. Nutr. 2015 13 1 1 22 10.20396/san.v13i1.1841
    [Google Scholar]
  83. Kennedy D. B Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review. Nutrients 2016 8 2 68 10.3390/nu8020068 26828517
    [Google Scholar]
  84. Ojewole J.A.O. Amabeoku G.J. Anticonvulsant effect of Persea americana Mill (Lauraceae) (Avocado) leaf aqueous extract in mice. Phytother. Res. 2006 20 8 696 700 10.1002/ptr.1940 16775810
    [Google Scholar]
  85. Kirkland A.E. Sarlo G.L. Holton K.F. The Role of Magnesium in Neurological Disorders. Nutrients 2018 10 6 730 10.3390/nu10060730 29882776
    [Google Scholar]
  86. Nehlig A. The neuroprotective effects of cocoa flavanol and its influence on cognitive performance. Br. J. Clin. Pharmacol. 2013 75 3 716 727 10.1111/j.1365‑2125.2012.04378.x 22775434
    [Google Scholar]
  87. Khalid W. Maqbool Z. Arshad M.S. Kousar S. Akram R. Siddeeg A. Ali A. Qin H. Aziz A. Saeed A. Rahim M.A. Zubair Khalid M. Ali H. Plant-derived functional components: prevent from various disorders by regulating the endocrine glands. Int. J. Food Prop. 2022 25 1 976 995 10.1080/10942912.2022.2070643
    [Google Scholar]
  88. Lee D.G. Lee Y. Shin H. Kang K. Park J.M. Kim B.K. Kwon O. Lee J.J. Seizures Related to Vitamin B6 Deficiency in Adults. J. Epilepsy Res. 2015 5 1 23 24 10.14581/jer.15006 26157671
    [Google Scholar]
  89. Ismail S. Eljazzar S. Ganji V. Intended and Unintended Benefits of Folic Acid Fortification—A Narrative Review. Foods 2023 12 8 1612 10.3390/foods12081612 37107407
    [Google Scholar]
  90. Silvestro S. Mammana S. Cavalli E. Bramanti P. Mazzon E. Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials. Molecules 2019 24 8 1459 10.3390/molecules24081459 31013866
    [Google Scholar]
  91. Tordjman S. Chokron S. Delorme R. Charrier A. Bellissant E. Jaafari N. Fougerou C. Melatonin: Pharmacology, Functions and Therapeutic Benefits. Curr. Neuropharmacol. 2017 15 3 434 443 10.2174/1570159X14666161228122115 28503116
    [Google Scholar]
  92. Gómez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat. Rev. Neurosci. 2008 9 7 568 578 10.1038/nrn2421 18568016
    [Google Scholar]
  93. Wal A. Srivastava A. Verma N. Pandey S.S. Tyagi S. The Role of Nutraceutical Supplements in the Treatment of Irritable Bowel Syndrome: A Mini Review. Curr. Pediatr. Rev. 2024 20 1 66 75 10.2174/1573396319666230102121953 36593535
    [Google Scholar]
  94. Akyuz E. Paudel Y.N. Polat A.K. Dundar H.E. Angelopoulou E. Enlightening the neuroprotective effect of quercetin in epilepsy: From mechanism to therapeutic opportunities. Epilepsy Behav. 2021 115 107701 10.1016/j.yebeh.2020.107701 33412369
    [Google Scholar]
  95. Pasinetti G.M. Wang J. Ho L. Zhao W. Dubner L. Roles of resveratrol and other grape-derived polyphenols in Alzheimer’s disease prevention and treatment. Biochim. Biophys. Acta Mol. Basis Dis. 2015 1852 6 1202 1208 10.1016/j.bbadis.2014.10.006 25315300
    [Google Scholar]
  96. Thalkari A.B. Karwa P.N. Thorat V.M. Jadhav S.K. Overview of neutraceuticals. Research Journal of Pharmacology and Pharmacodynamics 2020 12 3 130 10.5958/2321‑5836.2020.00023.3
    [Google Scholar]
  97. Aqil M. Batra A. Cosmeceuticals and Cosme-Neutraceuticals: New Paradigms in Cosmetology; A Letter. Journal of Skin and Stem Cell 2020 6 1 10.5812/jssc.99298
    [Google Scholar]
  98. Seo E.Y. Ha A.W. Kim W.K. α-Lipoic acid reduced weight gain and improved the lipid profile in rats fed with high fat diet. Nutr. Res. Pract. 2012 6 3 195 200 10.4162/nrp.2012.6.3.195 22808342
    [Google Scholar]
  99. Shaheen H.M. Alsenosy A.A. Nuclear Factor Kappa B Inhibition as a Therapeutic Target of Nutraceuticals in Arthritis, Osteoarthritis, and Related Inflammation. Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases. Elsevier 2019 437 453 10.1016/B978‑0‑12‑813820‑5.00025‑8
    [Google Scholar]
  100. Muscolo A. Mariateresa O. Giulio T. Mariateresa R. Oxidative Stress: The Role of Antioxidant Phytochemicals in the Prevention and Treatment of Diseases. Int. J. Mol. Sci. 2024 25 6 3264 10.3390/ijms25063264 38542238
    [Google Scholar]
  101. Bega D. Malkani R. Alternative treatment of restless legs syndrome: an overview of the evidence for mind–body interventions, lifestyle interventions, and neutraceuticals. Sleep Med. 2016 17 99 105 10.1016/j.sleep.2015.09.009 26847981
    [Google Scholar]
  102. George J. Kulkarni C. Sarma G.R.K. Antiepileptic Drugs and Quality of Life in Patients with Epilepsy: A Tertiary Care Hospital-Based Study. Value Health Reg. Issues 2015 6 1 6 10.1016/j.vhri.2014.07.009 29698179
    [Google Scholar]
  103. Gharibnaseri Z. Kebriaeezadeh A. Nikfar S. Zamani G. Abdollahiasl A. Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children. Daru 2012 20 1 17 10.1186/2008‑2231‑20‑17 23351726
    [Google Scholar]
  104. Movahedpour A. Taghvaeefar R. Asadi-Pooya A.A. Karami Y. Tavasolian R. Khatami S.H. Soltani Fard E. Taghvimi S. Karami N. Rahimi Jaberi K. Taheri-Anganeh M. Ghasemi H. Nano‐delivery systems as a promising therapeutic potential for epilepsy: Current status and future perspectives. CNS Neurosci. Ther. 2023 29 11 3150 3159 10.1111/cns.14355 37452477
    [Google Scholar]
  105. Nasopoulou C. Karantonis H.C. Detopoulou M. Demopoulos C.A. Zabetakis I. Exploiting the anti-inflammatory properties of olive (Olea europaea) in the sustainable production of functional food and neutraceuticals. Phytochem. Rev. 2014 13 2 445 458 10.1007/s11101‑014‑9350‑8
    [Google Scholar]
  106. Wanjari A.S. Desai P.R. Standardization of Some Herbal and Neutraceuticals Product. Research Journal of Pharmacognosy and Phytochemistry 2015 7 3 133 10.5958/0975‑4385.2015.00023.0
    [Google Scholar]
  107. Thambi A. Chakraborty K. Brown and Red Marine Macroalgae as Novel Bioresources of Promising Medicinal Properties. J. Aquat. Food Prod. Technol. 2022 31 3 227 241 10.1080/10498850.2022.2035877
    [Google Scholar]
  108. Tamang J.P. Shin D.H. Jung S.J. Chae S.W. Functional Properties of Microorganisms in Fermented Foods. Front. Microbiol. 2016 7 578 10.3389/fmicb.2016.00578 27199913
    [Google Scholar]
  109. Mitsuoka T. Development of functional foods. Biosci. Microbiota Food Health 2014 33 3 117 128 10.12938/bmfh.33.117 25032085
    [Google Scholar]
  110. Büyükkaragöz A. Bas M. Sağlam D. Cengiz Ş.E. Consumers’ awareness, acceptance and attitudes towards functional foods in T urkey. Int. J. Consum. Stud. 2014 38 6 628 635 10.1111/ijcs.12134
    [Google Scholar]
  111. Asli E. Consumption of functional foods in Europe; a systematic review. Nutr Hosp. 2014 29 3 470 478
    [Google Scholar]
  112. Brečić R. Gorton M. Barjolle D. Understanding variations in the consumption of functional foods – evidence from Croatia. Br. Food J. 2014 116 4 662 675 10.1108/BFJ‑05‑2012‑0133
    [Google Scholar]
  113. Bradlee M.L. Mustafa J. Singer M.R. Moore L.L. High-protein foods and physical activity protect against age-related muscle loss and functional decline. J. Gerontol. Ser. A 2018 73 88 94 10.1093/gerona/glx070
    [Google Scholar]
  114. Zeng Y. Yang J. Du J. Pu X. Yang X. Yang S. Yang T. Strategies of Functional Foods Promote Sleep in Human Being. Curr. Signal Transduct. Ther. 2015 9 3 148 155 10.2174/1574362410666150205165504 26005400
    [Google Scholar]
  115. Al-Sheraji S.H. Ismail A. Manap M.Y. Mustafa S. Yusof R.M. Hassan F.A. Prebiotics as functional foods: A review. J. Funct. Foods 2013 5 4 1542 1553 10.1016/j.jff.2013.08.009
    [Google Scholar]
  116. Shiby V.K. Mishra H.N. Fermented milks and milk products as functional foods--a review. Crit. Rev. Food Sci. Nutr. 2013 53 5 482 496 10.1080/10408398.2010.547398 23391015
    [Google Scholar]
  117. Hou Y. Jiang J.G. Origin and concept of medicine food homology and its application in modern functional foods. Food Funct. 2013 4 12 1727 1741 10.1039/c3fo60295h 24100549
    [Google Scholar]
  118. Galvan D. Effting L. Cremasco H. Conte-Junior C.A. Recent applications of mixture designs in beverages, foods, and pharmaceutical health: A systematic review and meta-analysis. Foods 2021 10 8 1941 10.3390/foods10081941 34441717
    [Google Scholar]
  119. Tselaesele N. Bultosa G. Molapisi M. Makhabu S. Kobue-Lekalake R. Haki G.D. Sekwati-Monang B. Seifu E. Mokhawa G. Sonno K. Plant-based traditional foods and beverages of Gumare Village, Botswana. Food Production, Processing and Nutrition 2023 5 1 28 10.1186/s43014‑023‑00142‑3
    [Google Scholar]
  120. Dolgopolova I. Teuber R. Bruschi V. Consumers’ perceptions of functional foods: trust and food‐neophobia in a cross‐cultural context. Int. J. Consum. Stud. 2015 39 6 708 715 10.1111/ijcs.12184
    [Google Scholar]
  121. Thakur G. Bag M. Sanodiya B. Debnath M. Zacharia A. Bhadauriya P. Prasad G. Bisen P. Chlorophytum borivilianum: a white gold for biopharmaceuticals and neutraceuticals. Curr. Pharm. Biotechnol. 2009 10 7 650 666 10.2174/138920109789542084 19751181
    [Google Scholar]
  122. Mukherjee A.K. Kalita P. Unni B.G. Wann S.B. Saikia D. Mukhopadhyay P.K. Fatty acid composition of four potential aquatic weeds and their possible use as fish-feed neutraceuticals. Food Chem. 2010 123 4 1252 1254 10.1016/j.foodchem.2010.05.057
    [Google Scholar]
  123. Barani M. Sangiovanni E. Angarano M. Rajizadeh M.A. Mehrabani M. Piazza S. Gangadharappa H.V. Pardakhty A. Mehrbani M. Dell’Agli M. Nematollahi M.H. Phytosomes as Innovative Delivery Systems for Phytochemicals: A Comprehensive Review of Literature. Int. J. Nanomedicine 2021 16 6983 7022 10.2147/IJN.S318416 34703224
    [Google Scholar]
  124. Cetin-Karaca H. Newman M.C. Antimicrobial Efficacy of Natural Phenolic Compounds against Gram Positive Foodborne Pathogens. J. Food Res. 2015 4 6 14 10.5539/jfr.v4n6p14
    [Google Scholar]
  125. Bloch M.H. Mulqueen J. Nutritional supplements for the treatment of ADHD. Child Adolesc. Psychiatr. Clin. N. Am. 2014 23 4 883 897 10.1016/j.chc.2014.05.002 25220092
    [Google Scholar]
  126. Ernst E. Functional foods, neutraceuticals, designer foods: Innocent fad or counterproductive marketing ploy? Eur. J. Clin. Pharmacol. 2001 57 5 353 355 10.1007/s002280100327 11599652
    [Google Scholar]
  127. Ortega M.A. Fraile-Martínez Ó. García-Montero C. Alvarez-Mon M.A. Lahera G. Monserrat J. Llavero-Valero M. Mora F. Rodríguez-Jiménez R. Fernandez-Rojo S. Quintero J. Alvarez De Mon M. Nutrition, Epigenetics, and Major Depressive Disorder: Understanding the Connection. Front. Nutr. 2022 b 9 867150 10.3389/fnut.2022.867150 35662945
    [Google Scholar]
/content/journals/cff/10.2174/0126668629329853241028081157
Loading
A Review on Functional Foods and Nutraceuticals in the Management of Epilepsy
Bentham Science Publishers ; https://doi.org/10.2174/0126668629329853241028081157
/content/journals/cff/10.2174/0126668629329853241028081157
/content/journals/cff/10.2174/0126668629329853241028081157
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: neurodegeneration ; food bioactives ; human health ; epilepsy management ; Status epilepticus ; dietary therapy

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test